Search the web
Welcome, Guest
[Sign Out, My Account]

Sunday, August 30 2015 12:04pm ET - U.S. Markets Closed.
Industry Center - Drug Delivery
Industry Center > Drug Delivery
More On This Industry
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Diversified Utilities
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
·Tobacco Products, Other
Complete Industry List...
Morningstar Inc.
In-depth Company Dossier Reports on over 7,500 publicly traded U.S. companies. Click here for your free report.
Industry Market Summary
Drug Delivery
Composite Value: 1006.5
Today's Change: -1.58%
S&P 500: +0.06%
chart for
[Drug Delivery (^YHOh786)]
Drug Delivery News
Generex Announces Issuance of Buccal Insulin White Paper
Thu Aug 27 (PR Newswire)
WORCESTER, Mass. and TORONTO, Aug. 27, 2015 /PRNewswire/ -- Generex Biotechnology Corporation ( (GNBT) today announced the issuance of a white paper on the status of Generex Oral-lyn™, the Company's proprietary buccal insulin spray product. The white paper was presented to the August 19, 2015 annual meeting of the Company's stockholders by Dr. James H. Anderson, Jr., MD, the Company's Chief Scientific Advisor. The white paper may be viewed online on the Generex website. The white paper builds upon the recently announced success of the Company's initial efforts to enhance the Generex Oral-lyn™ formulation by increasing the concentration of insulin, which efforts were undertaken in concert with the University of Toronto's Center for Molecular Design and Pre-formulations (CMDP) ( through the University Health Network ( and the University of Guelph (
Generex Provides Update on Success of Buccal Insulin Formulation Enhancement Project - (CNW Group)
Generex Provides Update on Success of Buccal Insulin Formulation Enhancement Project - (PR Newswire)
More News on Drug Delivery: Latest News,
Industry Top Performers
Intraday Price Performance% ChangeMarket Cap
More Top Intraday Price Performers...
Market Capitalization% ChangeMarket Cap
WALGREENS BOOTS [W8A.DE] -1.84% $84.6 B
Valeant Pharmaceuticals Interna [VRX] +0.52% $80.9 B
CLINIGEN GRP [CLIN.L] +0.94% $58.6 B
WALGREEN [WGN.DE] -1.14% $54.9 B
FRAGUA-B [FRAGUAB.MX] 0.00% $23.9 B
More Top Companies by Market Cap...
More Top Performers: by Valuation, by Growth, by Financial Strength
Industry Calendar
Upcoming Events
Date Co Event
10/29/15 RADL3.SA Raia Drogasil SA Q3 2015 Earnings Release
11/11/15 BPHA3.SA Brasil Pharma SA Q3 2015 Earnings Release
More Upcoming Events...
Recent Events
Date Co Event
08/13/15 BPHA3.SA BR PHARMA ON NM downside earnings surprise (-120.00%)
08/11/15 BPTH Bio-Path Holdings, Inc. upside earnings surprise (+66.67%)
08/11/15 INSV INSITE VISION INC downside earnings surprise (-150.00%)
More Recent Events...
Sponsor Results
GenomeWeb News
The life science community's home page for news and information
(What's This?)
Locate Industry by Company
Enter Symbol:
Industry Statistics
Market Capitalization:264B
Price / Earnings:111.5
Price / Book:-13.2
Net Profit Margin (mrq):8.2%
Price To Free Cash Flow (mrq):53.0
Return on Equity:8.0%
Total Debt / Equity:188.4
Dividend Yield:0.2%
View Industry Browser
Community Spotlight
Most Active Boards
Board Popularity
Unusually Active Boards
Board Variance

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Delivery Headlines
More Finance RSS Feeds

Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?